These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 17300168
1. Towards a new generation of potential antipsychotic agents combining D2 and 5-HT1A receptor activities. Cuisiat S, Bourdiol N, Lacharme V, Newman-Tancredi A, Colpaert F, Vacher B. J Med Chem; 2007 Feb 22; 50(4):865-76. PubMed ID: 17300168 [Abstract] [Full Text] [Related]
2. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum. Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D. Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244 [Abstract] [Full Text] [Related]
3. Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells. Heusler P, Newman-Tancredi A, Loock T, Cussac D. Eur J Pharmacol; 2008 Feb 26; 581(1-2):37-46. PubMed ID: 18190908 [Abstract] [Full Text] [Related]
7. Structure-activity relationship studies of CNS agents. XII. 1-[4-(4-aryl-1-piperazinyl)butyl]-3,4-dihydro-2(1H)-quinolinones: new 5-HT1A, 5-HT2 and D2 ligands with a potential antipsychotic activity. Mokrosz JL, Chojnacka-Wójcik E, Dereń-Wesołek A, Kłodzińska A, Maćkowiak M, Bielecka Z, Paluchowska MH. Drug Des Discov; 1994 Apr 26; 11(3):197-203. PubMed ID: 7548635 [Abstract] [Full Text] [Related]